Jonathan Behr
Partner at SV Health Investors
Jonathan Behr
Partner at SV Health Investors
Cambridge, Massachusetts
Overview
Work Experience
Board Observer
2024 - Current
Partner
2019
The Dementia Discovery Fund (DDF) is a venture capital fund, delivering both high-impact therapeutics for age related dementias and financial returns by investing in, creating, and supporting innovative companies. I am responsible for helping to build the Fund’s investment portfolio by leading investments in new and established companies, working closely with the Fund’s existing portfolio companies in advisor and director roles, and developing and driving DDF’s investment strategy in collaboration with the leadership team. The DDF is managed by SV Health Investors, a healthcare and life sciences venture capital and growth equity firm.
Partner
2019
Board Observer
2024
Member Board of Directors
2023
Member Board of Directors
2020
Board Observer
2022
Member Board of Directors
2020 - 2022
Board Observer
2022
Board Observer
2022
Independent Director, Parkinson's Research Ventures Ltd.
2023
The Parkinson’s UK Virtual Biotech (VB) programme was established in 2016 as a patient-led programme to discover and develop new treatments for Parkinson’s. It represents a core element of the strategy of the Parkinson’s UK charity (the “Charity”) to accelerate breakthroughs in research. Parkinson's Research Ventures (PRV) is a wholly-owned subsidiary of the Charity and was established in 2018 as a vehicle through which many of the financing and IP transactions for the VB Programme would be pursued. I am a volunteer independent director on the board of PRV.